Abstract
Non-segmental vitiligo (NSV) is a chronic autoimmune skin disease marked by melanocyte loss and depigmented macules. While clinical features are well recognized, immunohistological correlates such as Melan-A expression and CD8⁺ T-cell infiltration remain undercharacterized. To examine the clinical, histological, and immunohistochemical features of NSV, with a focus on their relationship to disease severity. In this prospective case-control study, 25 NSV patients and 25 matched healthy controls were evaluated using standardized scoring systems (VASI, VIDA, VETF, VETI). Biopsies from lesional, marginal, and normal skin underwent immunohistochemical staining for Melan-A and CD8⁺ T cells. Histopathological changes were graded using a structured scoring system. Lesional skin exhibited significant melanocyte loss (Melan-A⁺ median: 5 [IQR: 3-8]) and elevated CD8⁺ T-cell infiltration (median: 15 [10-18]) compared to controls (p < 0.001). Marginal zones showed intermediate values, indicating subclinical immune activation. CD8⁺ infiltration positively correlated with VASI (r = 0.53), while Melan-A expression showed a negative correlation (r = - 0.55). Both markers were independent predictors of disease severity. NSV exhibits a spatial immunohistological gradient, where melanocyte loss and CD8⁺ T-cell infiltration parallel clinical severity. The integration of immunophenotyping with clinical scoring provides a novel biomarker strategy for personalized therapy.